Topic Hub
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 14 of 14 clinical reviews.
A clinician-reviewed guide to transitioning adolescents aged 12 to 17 from oral micronized progesterone (Prometrium) to adult hormone care, covering dosing, monitoring, insurance continuity, and guideline-based recommendations.
Read clinical reviewA clinician-reviewed guide to managing sedation, timing, and daily life for adolescents aged 12-17 taking oral micronized progesterone (Prometrium), covering school performance, sports, and sleep scheduling.
Read clinical reviewComplete caregiver guide to administering oral micronized progesterone (Prometrium) to adults aged 65 and older, including dosing, timing, fall-risk precautions, and monitoring protocols reviewed by the HealthRX medical team.
Read clinical reviewA clinical deep-dive into how oral micronized progesterone (Prometrium) affects bone, brain, uterine, and metabolic development in adolescents aged 12 to 17, with dosing guidance, safety data, and physician-reviewed recommendations.
Read clinical reviewA clinical review of off-label oral micronized progesterone (Prometrium) use in adolescents ages 12 to 17, covering evidence base, dosing protocols, safety data, and prescribing considerations for primary amenorrhea, luteal phase support, and HPA-axis-related conditions.
Read clinical reviewA clinician-reviewed guide to how oral micronized progesterone (Prometrium) affects older adults, covering cognitive effects, fall risk, cardiovascular considerations, sleep, and prescribing guidance for patients 65+.
Read clinical reviewA clinician-reviewed guide to oral micronized progesterone (Prometrium) safety, sedation risk, and activity planning for adults aged 65 and older, with dosing context, fall-risk data, and practical scheduling advice.
Read clinical reviewComplete caregiver guide for giving oral micronized progesterone (Prometrium) to children under 12, including dosing considerations, safety data, administration tips, and when to call the prescriber.
Read clinical reviewA clinical review of oral micronized progesterone (Prometrium) use in pediatric patients under age 12, covering developmental safety, neuroactive steroid mechanisms, preterm birth data, and what current evidence supports.
Read clinical reviewA clinical guide for parents and prescribers on how oral micronized progesterone (Prometrium) affects attention, sleep, fatigue, and physical activity in pediatric patients under age 12, with evidence-based dosing and monitoring strategies.
Read clinical reviewA clinical guide to oral micronized progesterone (Prometrium) for patients 65 and older transitioning to adult care, covering dosing, safety, fall risk, and monitoring.
Read clinical reviewA comprehensive clinical review of oral micronized progesterone (Prometrium) off-label use in children under 12, covering indications, dosing frameworks, safety data, and guideline positions.
Read clinical reviewA clinical guide to oral micronized progesterone (Prometrium) use in children under 12, covering off-label rationale, safety monitoring, and the structured handoff to adult endocrine or gynecologic care.
Read clinical reviewA clinician-reviewed guide for caregivers administering oral micronized progesterone (Prometrium) to adolescents aged 12 to 17, covering dosing schedules, safety monitoring, storage, and when to call the prescriber.
Read clinical review